Eledon Pharmaceuticals Statistics Share Statistics Eledon Pharmaceuticals has 59.88M
shares outstanding. The number of shares has increased by 51%
in one year.
Shares Outstanding 59.88M Shares Change (YoY) 51% Shares Change (QoQ) 0% Owned by Institutions (%) 49.85% Shares Floating 55.34M Failed to Deliver (FTD) Shares 5,104 FTD / Avg. Volume 0.8%
Short Selling Information The latest short interest is 3.11M, so 5.19% of the outstanding
shares have been sold short.
Short Interest 3.11M Short % of Shares Out 5.19% Short % of Float 5.8% Short Ratio (days to cover) 5.4
Valuation Ratios The PE ratio is -5.66 and the forward
PE ratio is -2.83.
Eledon Pharmaceuticals's PEG ratio is
0.
PE Ratio -5.66 Forward PE -2.83 PS Ratio 0 Forward PS n/a PB Ratio 1.69 P/FCF Ratio -4.23 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Eledon Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 12.42,
with a Debt / Equity ratio of 0.01.
Current Ratio 12.42 Quick Ratio 12.42 Debt / Equity 0.01 Debt / EBITDA -0.03 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.14M Employee Count 31 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 431K Effective Tax Rate -1.21%
Stock Price Statistics The stock price has increased by 1.88% in the
last 52 weeks. The beta is -0.14, so Eledon Pharmaceuticals's
price volatility has been lower than the market average.
Beta -0.14 52-Week Price Change 1.88% 50-Day Moving Average 3.16 200-Day Moving Average 3.71 Relative Strength Index (RSI) 37.36 Average Volume (20 Days) 635,717
Income Statement
Revenue n/a Gross Profit n/a Operating Income -70.58M Net Income -35.32M EBITDA -35.39M EBIT -35.75M Earnings Per Share (EPS) -0.73
Full Income Statement Balance Sheet The company has 20.55M in cash and 954K in
debt, giving a net cash position of 19.59M.
Cash & Cash Equivalents 20.55M Total Debt 954K Net Cash 19.59M Retained Earnings -355.59M Total Assets 161.31M Working Capital 118.53M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -47.27M
and capital expenditures 0, giving a free cash flow of -47.27M.
Operating Cash Flow -47.27M Capital Expenditures n/a Free Cash Flow -47.27M FCF Per Share -0.97
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ELDN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for ELDN is $12.5,
which is 361.3% higher than the current price. The consensus rating is "Buy".
Price Target $12.5 Price Target Difference 361.3% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 5, 2020. It was a
backward
split with a ratio of 1:18.
Last Split Date Oct 5, 2020 Split Type backward Split Ratio 1:18
Scores Altman Z-Score -1.74 Piotroski F-Score 1
